Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences Choi MK; Song ISDrug Metab Pharmacokinet 2008[]; 23 (4): 243-53To clarify the considerable interindividual variability in the pharmacokinetics, efficacy, and toxicity of drugs, genetic polymorphism of drug transporters has attracted interest because these transporters play important roles in the gastrointestinal absorption, biliary and renal elimination, and distribution to target sites of their substrates. Of the over 325 members of the solute carrier superfamily, this review focuses on the molecular features, expressional regulation, and genetic polymorphisms of the organic cation transporter (OCT) family, and the pharmacokinetic or pharmacodynamic consequences for organic cationic drugs. Although the clinical significance is still unclear, many studies have reported the importance of OCTs in the tissue distribution and elimination of their substrates in vitro and in vivo, and the impact of functional non-synonymous single nucleotide polymorphisms or differential expression levels of OCTs on the large interindividual variation in the pharmacokinetics and response of organic cationic drugs such as metformin, imatinib, and cisplatin.|Animals[MESH]|Benzamides[MESH]|Cisplatin/toxicity[MESH]|Humans[MESH]|Imatinib Mesylate[MESH]|Kidney/drug effects[MESH]|Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy[MESH]|Metformin/pharmacokinetics/pharmacology[MESH]|Organic Cation Transport Proteins/chemistry/genetics/*physiology[MESH]|Piperazines/therapeutic use[MESH]|Polymorphism, Single Nucleotide[MESH]|Pyrimidines/therapeutic use[MESH]|Substrate Specificity[MESH] |
